Abstract: A battery can include an electrode assembly, a battery housing, a terminal and a cap. The electrode assembly can have a first electrode, a second electrode and a separator between the first electrode and the second electrode. Each of the first electrode and the second electrode can have a first portion including an active material corresponding to the separator, and a second portion exposed beyond the separator and not coated with the active material. The battery housing can have a first end with a first opening and a second end with a second opening opposite the first end. The terminal can be electrically connected to the second portion of the first electrode and exposed out of the battery housing through the first opening of the battery housing at the first end.

Abstract: Therapeutic compounds for red blood cell-mediated delivery of an active pharmaceutical ingredient to a target cell are described. The therapeutic compounds are configured to bind CD47 on the surface of a red blood cell and to be subsequently transferred to CD47 on the surface of the target cell, the therapeutic compound ultimately being internalized by the target cell via endocytosis. The target cell may be a cancer cell.

Abstract: The machine learning method for a LiDAR-based deep learning object perception apparatus comprises preparing an original dataset of a LiDAR point cloud; acquiring virtual object datasets from a point cloud database; adding the virtual object datasets to the original dataset based on an association of position information for each object to acquire a learning dataset; and training the LiDAR-based deep learning object perception apparatus using the learning dataset.

Abstract: A battery, includes an electrode assembly having a first electrode, a second electrode and a separator, wherein each of the first electrode and the second electrode has a first portion including an active material corresponding to the separator, and a second portion exposed beyond the separator and not coated with the active material; a battery housing having a first end with a first opening and a second end with a second opening opposite the first end, the battery housing accommodating the electrode assembly through the second opening at the second end and electrically connected to the second portion of the second electrode; a terminal electrically connected to the second portion of the first electrode and exposed out of the battery housing through the first opening of the battery housing at the first end; and a cap covering and sealing the second opening at the second end of the battery housing.

Abstract: Disclosed is a composition for promoting hair growth and ameliorating, preventing or treating hair loss containing 2?-fucosyllactose (2?-FL) as an active ingredient, and a method for promoting hair growth or ameliorating, preventing or treating hair loss, the method comprising administering to a subject in need thereof 2?-fucosyllactose. Treatment with a combination of testosterone and 2?-fucosyllactose increases hair gloss, increases hair length, reduces a hair loss area, enhances hair cuticles, increases the number and size of hair follicles, and improves expression of proteins and genes related to hair proliferation and growth, compared to treatment with testosterone alone, thus being applicable as a substance for various food and pharmaceutical compositions based on effects of promoting hair growth, improving hair loss, and ameliorating, preventing or treating hair loss.

Abstract: A battery can include an electrode assembly including a first electrode, a second electrode, and a separator between the first electrode and the second electrode. The first electrode can have a pair of first sides and a pair of second sides extending between the pair of first sides, a first portion including an active material extending between the pair of first sides, and a second portion extending between the pair of first sides and exposed beyond the separator along a winding direction. The battery can further include a battery housing having a first opening at a first end and a second end with a second opening opposite the first end, a first current collector including a support portion positioned on the electrode assembly, and a housing cover which seals the first opening.

Abstract: Disclosed herein are a microbubble-extracellular vesicle complex, a production method therefor, and a system for driving the same. In one aspect, preferred microbubble-extracellular vesicle complexes may comprise an ultrasound contrast agent-based microbubble, an extracellular cell derived from a natural killer cell (NK cell), a human glial cell, or a human mesenchymal stem cell, and a coupling medium and can be derive in a 3D mode using ultrasonic waves and deliver a drug loaded in the extracellular vesicle to a target site.

Abstract: The present disclosure relates to a hydrogen purification/storage apparatus and method using a liquid organic hydrogen carrier (LOHC).

Abstract: The present application relates to a plant-soaked solution comprising sugars containing tagatose and to a method for producing same.

Abstract: Therapeutic compounds for red blood cell-mediated delivery of an active pharmaceutical ingredient to a cancer cell are described. The therapeutic compounds are configured to bind CD47 on the surface of a red blood cell and to be subsequently transferred to CD47 on the surface of the cancer cell, the therapeutic compound ultimately being internalized by the cancer cell via endocytosis.

Abstract: A battery pack includes a plurality of battery modules including module cases. Side surfaces of the module cases in which battery cells are accommodated face each other and a water injection hole is formed in a top surface of each of the module cases, and a fire extinguishing tank unit containing a fire extinguishing agent, located over the plurality of battery modules, and configured to supply the fire extinguishing agent only into a battery module in which a thermal event occurs from among the plurality of battery modules through the water injection holes.

Abstract: Proposed are an apparatus for delivering radio frequency and a control method thereof. The apparatus includes a body configured to control an overall operation, a handpiece connected to the body and configured to be operated by receiving power from the body, and a tip which is attached to a first side surface of the handpiece and which is in close contact with skin of a user. The body includes a first power source unit, a first control unit, a storage unit, an energy generation unit, and a cooling unit. The handpiece includes a second power source unit, a second control unit, an energy transferring unit, and a gas transferring unit. The tip includes a housing, an electrode unit, a data collection unit, and a chamber.

Abstract: Disclosed is a composition containing 2?-FL for ameliorating, preventing or treating diseases caused by reduction of dopamine. 2?-FL has an advantage of effectively preventing or treating diseases caused by a decrease in dopamine by effectively suppressing degeneration of dopaminergic neurons. In particular, the composition of the present invention is effective in preventing, treating, or ameliorating Parkinson's disease caused by reduction of dopamine because it contains 2?-fucosyllactose (2?-FL) as an active ingredient, thereby suppressing the decrease in dopaminergic neurons and exhibiting an effect of improving motor activity.

Abstract: The present invention improves a heat dissipation property of a semiconductor device by transferring hexagonal boron nitride (hBN) with a two-dimensional nanostructure to the semiconductor device. A semiconductor device of the present invention includes a substrate having a first surface and a second surface, a semiconductor layer formed on the first surface of the substrate, an hBN layer formed on at least one surface of the first surface and the second surface of the substrate, and a heat sink positioned on the second surface of the substrate. A radiation rate of heat generated during driving of an element is increased to decrease a reduction in lifetime of a semiconductor device due to a temperature increase. The semiconductor device has a structure and configuration which are very effective in improving a rapid temperature increase due to heat generated by high-power semiconductor devices.

Abstract: A display device includes a lower metal layer disposed on a surface of a substrate and including a first opening overlapping a rear emission pixel in a plan view; a first electrode and a second electrode disposed in each of the rear emission pixel and a front emission pixel, the first electrode and the second electrode being spaced apart from each other on the lower metal layer; first light emitting elements disposed between the first electrode and the second electrode disposed in the rear emission pixel; second light emitting elements disposed between the first electrode and the second electrode disposed in the front emission pixel; and a reflective layer disposed on the first light emitting elements and overlapping the rear emission pixel in a plan view, the reflective layer overlaps at least one of the first light emitting elements in a plan view.

Abstract: The present invention relates to a derivative compound in which a biphenyl group is introduced into an aminoalkanoic acid, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The compound of the present invention exhibits excellent antifungal and fungicidal effects. Furthermore, the compound of the present invention exhibits a synergistic effect when used in combination with a conventional antifungal agent. Furthermore, the compound of the present invention provides broad-spectrum antifungal activity against a wide range of fungal pathogens. Therefore, the compound of the present invention may be widely used in fields requiring treatment with antifungal or fungicidal agents against human pathogenic fungi and animal pathogenic fungi, and phytopathogenic fungi.

Abstract: An electrode assembly includes a first electrode; a second electrode; and a separator, the first electrode, the second electrode, and the separator wound about an axis defining a core and an outer circumference of the electrode assembly. The first electrode has a pair of first sides and a pair of second sides, a first portion extending between the pair of first sides, and a second portion extending between the pair of first sides, the first portion being coated with an active material, and at least a part of the second portion includes an electrode tab. The second portion includes a first part adjacent to the core of the electrode assembly, a second part adjacent to the outer circumference of the electrode assembly, and a third part between the first part and the second part. The first or second part has a smaller height than the third part.

Abstract: A battery can include an electrode assembly having a first electrode, a second electrode and a separator. The first electrode can include a first active material region coated with an active material layer along a winding direction and a first uncoated region not coated with the active material layer, and at least part of the first uncoated region used as an electrode tab. The battery can further include a first current collector coupled to at least part of the first uncoated region on the electrode assembly, a battery housing to accommodate the electrode assembly and the first current collector, and an insulator between an inner surface of the battery housing facing the first uncoated region or the first current collector and the first uncoated region or the first current collector to block the electrical connection between the first uncoated region and the battery housing.

Abstract: The present disclosure provides a compound of Chemical Formula (1) or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same: wherein X, Z, R1 and R2 are as defined in the specification. The compound of Chemical Formula (1) or pharmaceutically acceptable salt thereof acts as a positive allosteric modulator of metabotropic glutamate receptor subtype 5 (mGluR5), thereby being useful in the prevention or treatment of disorder mediated by glutamate dysfunction and mGluR5.

Abstract: A transceiver includes a transmitter and a receiver connected to each other through a first line and a second line. The transmitter transmits signals having a first voltage range to the first line and the second line in a first mode, and transmits signals having a second voltage range less than the first voltage range to the first line and the second line in a second mode. In transmitting a (1?1)-th payload to the receiver, the transmitter is sequentially driven in the first mode, the second mode, and the first mode, and transmits a first clock training pattern and the (1?1)-th payload in the second mode. The receiver includes a clock data recovery circuit generating a first clock signal corresponding to the received first clock training pattern and a register storing first frequency information and first phase information of the first clock training pattern.